{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:20:57Z","timestamp":1790936457491,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1007\/s11906-004-0006-8","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T05:19:21Z","timestamp":1179983961000},"page":"21-26","source":"Crossref","is-referenced-by-count":17,"title":["Genetics of vasopressin receptors"],"prefix":"10.1007","volume":"6","author":[{"given":"Marc","family":"Thibonnier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"6_CR1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.pharmtox.41.1.593","volume":"41","author":"BK Rana","year":"2001","unstructured":"Rana BK, Shiina T, Insel PA: Genetic variations and polymorphisms of G protein-coupled receptors: functional and therapeutic implications. Annu Rev Pharmacol Toxicol 2001, 41:593\u2013624.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"6_CR2","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0092-8674(93)90609-T","volume":"75","author":"DE Clapham","year":"1994","unstructured":"Clapham DE: Mutations in G protein-linked receptors: novel insights on disease. Cell 1994, 75:1237\u20131239.","journal-title":"Cell"},{"key":"6_CR3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/jim-51-04-21","volume":"51","author":"WF Simonds","year":"2003","unstructured":"Simonds WF: G protein-regulated signaling dysfunction in human disease. J Investig Med 2003, 51:194\u2013214.","journal-title":"J Investig Med"},{"key":"6_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.pharmtox.41.1.175","volume":"41","author":"M Thibonnier","year":"2001","unstructured":"Thibonnier M, Coles P, Thibonnier A, Shoham M: The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists. Annu Rev Pharmacol Toxicol 2001, 41:175\u2013202. Comprehensive review of the physiology and pharmacology of vasopressin receptors and their nonpeptide receptor antagonists.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"6_CR5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-4615-4871-3_34","volume":"449","author":"M Thibonnier","year":"1998","unstructured":"Thibonnier M, Conarty DM, Preston JA, et al.: Molecular pharmacology of human vasopressin receptors. Adv Exp Med Biol 1998, 449:251\u2013276.","journal-title":"Adv Exp Med Biol"},{"key":"6_CR6","first-page":"605","volume-title":"Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research","author":"DG Bichet","year":"1995","unstructured":"Bichet DG, Lonergan M, Arthus MF, et al.: Nephrogenic diabetes insipidus due to mutations in AVPR2 and AQP2. In Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research. Edited by Saito T, Kurokawa K, Yoshida S. Amsterdam: Elsevier Science; 1995:605\u2013613."},{"key":"6_CR7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/10799899509045213","volume":"15","author":"M Birnbaumer","year":"1995","unstructured":"Birnbaumer M: Mutations and diseases of G protein coupled receptors. J Recept Signal Transduct Res 1995, 15:131\u2013160.","journal-title":"J Recept Signal Transduct Res"},{"key":"6_CR8","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1681\/ASN.V8121951","volume":"8","author":"DG Bichet","year":"1997","unstructured":"Bichet DG, Oksche A, Rosenthal W: Congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 1997, 8:1951\u20131958.","journal-title":"J Am Soc Nephrol"},{"key":"6_CR9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s001090050224","volume":"76","author":"A Oksche","year":"1998","unstructured":"Oksche A, Rosenthal W: The molecular basis of nephrogenic diabetes insipidus. J Mol Med 1998, 76:326\u2013337.","journal-title":"J Mol Med"},{"key":"6_CR10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.physiol.63.1.607","volume":"63","author":"JP Morello","year":"2001","unstructured":"Morello JP, Bichet DG: Nephrogenic diabetes insipidus. Annu Rev Physiol 2001, 63:607\u2013630. Thorough description of nephrogenic diabetes insipidus and related mutations of the vasopressin receptor.","journal-title":"Annu Rev Physiol"},{"key":"6_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1073\/pnas.98.1.93","volume":"98","author":"LS Barak","year":"2001","unstructured":"Barak LS, Oakley RH, Laporte SA, Caron MG: Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proc Natl Acad Sci U S A 2001, 98:93\u201398.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR12","doi-asserted-by":"crossref","first-page":"11981","DOI":"10.1021\/bi020275m","volume":"41","author":"AM Wilbanks","year":"2002","unstructured":"Wilbanks AM, Laporte SA, Bohn LM, et al.: Apparent lossof-function mutant GPCRs revealed as constitutively desensitized receptors. Biochemistry 2002, 41:11981\u201311989.","journal-title":"Biochemistry"},{"key":"6_CR13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI8688","volume":"105","author":"JP Morello","year":"2000","unstructured":"Morello JP, Salahpour A, Laperri\u00e8re A, et al.: Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 2000, 105:887\u2013895. Seminal work demonstrating the rescue of misfolded vasopressin receptors by cell-permeant nonpeptide antagonists.","journal-title":"J Clin Invest"},{"key":"6_CR14","doi-asserted-by":"crossref","first-page":"35678","DOI":"10.1074\/jbc.M301888200","volume":"278","author":"CM Tan","year":"2003","unstructured":"Tan CM, Nickols HH, Limbird LE: Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation. J Biol Chem 2003, 278:35678\u201335686.","journal-title":"J Biol Chem"},{"key":"6_CR15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/sj.mp.4001195","volume":"7","author":"SR Wersinger","year":"2002","unstructured":"Wersinger SR, Ginns EI, O\u2019Carroll AM, et al.: Vasopressin V1b receptor knockout reduces aggressive behavior in male mice. Mol Psychiatry 2002, 7:975\u2013984.","journal-title":"Mol Psychiatry"},{"key":"6_CR16","first-page":"2029","volume":"83","author":"G Arnaldi","year":"1998","unstructured":"Arnaldi G, Gasc J, de Clauser E, Bertagna X: Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors. J Endocrinol Metab 1998, 83:2029\u20132035.","journal-title":"J Endocrinol Metab"},{"key":"6_CR17","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1210\/jc.2002-020067","volume":"87","author":"T Mune","year":"2002","unstructured":"Mune T, Murase H, Yamakita N, et al.: Eutopic overexpression of vasopressin V1a receptor in adrenocorticotropinindependent macronodular adrenal hyperplasia. J Clin Endocrinol Metab 2002, 87:5706\u20135713. Example of overexpression of vasopressin receptors in endocrine tumors.","journal-title":"J Clin Endocrinol Metab"},{"key":"6_CR18","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI118547","volume":"97","author":"Y Keyser De","year":"1996","unstructured":"De Keyser Y, Lenne F, Auzan C, et al.: The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. J Clin Invest 1996, 97:1311\u20131318.","journal-title":"J Clin Invest"},{"key":"6_CR19","first-page":"1768","volume":"81","author":"PL Dahia","year":"1996","unstructured":"Dahia PL, Ahmed-Shuaib A, Jacobs RA, et al.: Vasopressin receptor expression and mutation analysis in corticotropinsecreting tumors. J Clin Endocrinol Metab 1996, 81:1768\u20131771.","journal-title":"J Clin Endocrinol Metab"},{"key":"6_CR20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2826.2002.00834.x","volume":"14","author":"P Rene","year":"2002","unstructured":"Rene P, Grino M, Viollet C, et al.: Overexpression of the V3 vasopressin receptor in transgenic mice corticotropes leads to increased basal corticosterone. J Neuroendocrinol 2002, 14:737\u2013744. Example of overexpression of vasopressin receptors in endocrine tumors.","journal-title":"J Neuroendocrinol"},{"key":"6_CR21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/00129785-200303010-00008","volume":"3","author":"KM Small","year":"2003","unstructured":"Small KM, Tanguay DA, Nandabalan K, et al.: Gene and protein domain-specific patterns of genetic variability within the Gprotein coupled receptor superfamily. Am J Pharmacogenomics 2003, 3:65\u201371.","journal-title":"Am J Pharmacogenomics"},{"key":"6_CR22","first-page":"553","volume-title":"Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research","author":"M Thibonnier","year":"1995","unstructured":"Thibonnier M, Jeunemaitre X, Graves MK, et al.: Structure of the human V1a vasopressin receptor gene. In Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research. Edited by Saito T, Kurokawa T, Yoshida S. Amsterdam: Elsevier Science; 1995:553\u2013571."},{"key":"6_CR23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1006\/jmcc.2000.1108","volume":"32","author":"M Thibonnier","year":"2000","unstructured":"Thibonnier M, Graves MK, Wagner MS, et al.: Study of V(1)-vascular vasopressin receptor gene microsatellite polymorphisms in human essential hypertension. J Mol Cell Cardiol 2000, 32:557\u2013564. Role of vasopressin receptor polymorphism in a complex trait.","journal-title":"J Mol Cell Cardiol"},{"key":"6_CR24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.mp.4001125","volume":"7","author":"SJ Kim","year":"2002","unstructured":"Kim SJ, Young LJ, Gonen D, et al.: Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism. Mol Psychiatry 2002, 7:503\u2013507.","journal-title":"Mol Psychiatry"},{"key":"6_CR25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s100380200002","volume":"47","author":"CH Chen","year":"2002","unstructured":"Chen CH, Chen WY, Liu HL, et al.: Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients. J Hum Genet 2002, 47:66\u201373.","journal-title":"J Hum Genet"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-004-0006-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-004-0006-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-004-0006-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T03:11:16Z","timestamp":1628910676000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-004-0006-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1007\/s11906-004-0006-8","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}